Remove Business Development Remove Development Remove Life Science Remove Pharma Companies
article thumbnail

Where are the hottest drug discovery hubs in the US?

Drug Discovery World

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. But what does it take to implement these innovations?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

LSX Inv€$tival Showcase round-up

pharmaphorum

On 14th November, investors and life science & healthcare executives descended on London’s famed Old Billingsgate building to attend LSX’s Inv€$tival Showcase, part of Europe’s biggest dedicated healthcare investment week. Investing in the future of the European life sciences. For Müllenbeck, this is an opportunity.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. He said that this can be used to shape trials to make them easier for patients, with potential benefits in terms of adherence.

article thumbnail

Partnering to advance digital therapeutics offerings

pharmaphorum

Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . “Our capabilities are very complimentary. About the author .

article thumbnail

Top 5 Fastest Growing Pharma and Biotech Companies in 2024

XTalks

Here, we will deep-dive into the top five fastest growing pharma and biotech companies in 2024, showcasing their innovative strategies and inspiring achievements. Pfizer (Overall Rank 268) Leading the list is one of the most renowned pharma companies in the world: Pfizer. Vertex is growing at a CAGR of 28.97

article thumbnail

Empowering rare disease patient advocacy organisations with data

pharmaphorum

One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. External developers can use Komodo’s platform and build analytics modules to explore other use cases using low code or no-code environments. The business of data.